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Intr
Atrial fibrillation (AF) is a commonly encountered compli-
cation in intensive care. The causes of AF are widespread
& thought to be an electrolyte disturbance or altered intra-
vascular volume, but recent evidence suggesting that vaso-
pressor dose & raised MAP also are indicated. There is
little uniformity or guidance in the management of this
arrhythmia.
Objectives
New onset atrial fibrillation occurs in about 10% of
patients admitted to intensive care and has an adverse
effect on several outcome measures. The objective of this
audit was to assess the incidence of new onset AF in criti-
cal illness, its causes, treatments & to evaluate a proposed
target as laid by the Royal College of Anaesthetists
(RCOA).
Methods
Using the Philips Intel iView Clinical Information
Portfolio (ICIP), all patients who developed AF during
their admission to ICU were identified between March
2012 & June 2014. The records were examined for the
demographics, MAP,vasopressor dose, electrolytes
immediately prior to development of AF. The drug
charts were examined for evidence of rate & rhythm
control & anticoagulation. In addition the use of DCCV
& echocardiography were recorded.
Results
During the time period there were 1900 admissions to the
Unit. On examining the patient record, 203 patients devel-
oped AF during their ICU admission. In 60% patients the
MAP was ≥75 mmHg, with 7% on a dose of noradrenaline
> 0.3 mcg/kg/min. Nearly half of the patients had a diag-
nosis of severe sepsis or septic shock & in this group the
MAP≥75 mmHg in 60%.31% patients had rhythm control,
14% rate control & 7% both. Anticoagulation was
prescribed in only 15% patients. 38 patients had a docu-
mented ECHO. The median values for K+ & Mg2+ at the
onset of AF were 4.3 & 0.85 respectively.
Conclusions
The incidence of new AF in our ICU was 11%. It was not
just confined to those with greater disease severity as
defined by APACHE, but seen predominantly in those
with APACHE II < 25.Interestingly the relation between
higher MAP& AF seen in the SEPSISSPAM was repeated
in our patient cohort. As a common practice ensuring K+
& Mg2+ greater than 4.5 mmol/l &1 mmol/l respectively
to treat AF seems to be an appropriate management strat-
egy in absence of well documented evidence. Small pro-
portion of patients received an ECHO, which we believe
to be a result of the constraints on the echocardiography
service. We know that transthoracic echocardiography
(TTE) diagnosed left ventricular dysfunction, increased left
atrial diameter and valvular abnormality were associated
with increased risk of stroke, thromboembolism and
mortality. Hence it’s both clinically relevant & cost effec-
tive to perform an ECHO. Lastly few patients received the
standard of care documented by the RCOA.
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